icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL 2017 - European Association for the
Study of the Liver
Amsterdam, The Netherlands. 2017
Back grey_arrow_rt.gif
Safety and Efficacy of Sofosbuvir/Velpatasvir for the Treatment of Chronic Hepatitis C in Patients Aged 65 Years or Older: A Retrospective Analysis of Phase 3 Studies
  Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Mark Sulkowski1, Graham R. Foster2, Mitchell Shiffman3, Sean Byrne4, John Wolf4, Chester Grabowski4, John McNally4, Diana M Brainard4, Kyle Etzkorn5, Aasim Sheikh6, Jordan Feld7 1Johns Hopkins University, Baltimore, MD, United States; 2Liver Unit, Queen Mary Hospital, University of London, Barts Health London, United Kingdom; 3Bon Secours Virginia Health System, Liver Institute of Virginia, Richmond, VA, United States. 4Gilead Sciences Inc., Foster City, CA, United States; 5Borland-Groover Clinic, Jacksonville, FL, United States; 6Gastrointestinal Specialists of Georgia, Marietta, GA, United States; 7Western Hospital Liver Centre, Toronto, ON, Canada